People Background Check
Find People:

Gordon W Laurie, Age 70919 Saint Clair Ave, Charlottesville, VA 22901

Get Report
Known as:
Gordon Dr Laurie
Related to:
Mary M Laurie 36 Diane Elizabeth Laurie 34

Gordon Laurie Phones & Addresses

919 Saint Clair Ave, Charlottesvle, VA 22901 (434) 293-4971

Charlottesville, VA

Rockville, MD

Mentions for Gordon W Laurie

Gordon Laurie resumes & CV records

Resumes

Gordon Laurie Photo 31

Associate Professor & Director Of Biotechnology Training Program At Department Of Cell Biology, University Of Virginia

Position:
Founder at TearSolutions LLC, Associate Professor & Director of Biotechnology Training Program at Department of Cell Biology, University of Virginia
Location:
Charlottesville, Virginia Area
Industry:
Higher Education
Work:
TearSolutions LLC - Charlottesville, Virginia Area since May 2013
Founder Department of Cell Biology, University of Virginia - Charlottesville, Virginia Area since 1988
Associate Professor & Director of Biotechnology Training Program NIH - Bethesda, MD 1983 - 1988
Postdoc National Institutes of Health - Bethesda, MD Jul 1983 - Jul 1988
Visiting Associate
Education:
McGill University 1977 - 1982
MSc, PhD, Cell Biology McMaster University 1972 - 1976
BSc, Biology
Interests:
A unifying understanding of the physiology of the surface of the eye towards the alleviation of disease. Lacritin cellular mechanisms.
Honor & Awards:
Awards 2004, Virginia Biotechnology Educator of the Year Award 2007, NIH Director’s Bridge Award 2010, ARVO Fellow (Silver) National Committees - Grant Review 2005, NIH Special Emphasis Panel NEI (Dry Eye/Glaucoma) 2005, 2008, NIH Anterior Eye Disease Study Section (ad hoc) 2007, NIH Special Emphasis Panel NIGMS Training Grants 2007, Natural Sciences and Engineering Research Council of Canada 2007, National Medical Research Council (Singapore) 2009, NIH Special Emphasis Panel/Scientific Review Group (Challenge grants) 2009, NIH Anterior Eye Disease Study Section (ad hoc) 2010, NIH Anterior Eye Disease Study Section (ad hoc) 2010, NIH Anterior Eye Disease ZRG1 AED-W (02) S 2011, NIH Anterior Eye Disease Study Section (ad hoc) 2012-15, ARVO Annual Meeting Program Committee (Corneal Section) 2013-17, NIGHMS Training and Workforce Development (TWD-B) Study Section Editorial 2008 - present, Executive Editor, Experimental Eye Research
Gordon Laurie Photo 32

Physical Therapist - Clinical Lead At Outpatient Clinic - Och

Position:
Physical Therapist - Clinical Lead at Intermountain Healthcare
Location:
Springville, Utah
Industry:
Hospital & Health Care
Work:
Intermountain Healthcare - Orem Community Hospital since Dec 2012
Physical Therapist - Clinical Lead Intermountain Physical Therapy - Saratoga Springs - Saratoga Springs, Utah Aug 2012 - Dec 2012
DPT Student Intern Orrock Mendenhall Professional Physical Therapy - Orem, Utah May 2012 - Aug 2012
DPT Student Intern Utah Valley Specialty Hospital - Provo, Utah Area Jan 2012 - Apr 2012
DPT Student Intern Holly Creek Independent Living Center - Centennial, Colorado Oct 2011 - Dec 2011
DPT Student Intern Utah Valley Pain Management Aug 2008 - Apr 2011
Physical Therapist Assistant AF Physical Therapy May 2008 - Jul 2008
Student Extern Second Nature Therapeutic Programs Jun 1999 - Jul 2008
Transporter Uinta Basin Physical Therapy Sep 2007 - Oct 2007
Student Extern Sandy Regional Nursing Facility Jun 2007 - Jul 2007
Student Extern
Education:
Rocky Mountain University of Health Professions 2010 - 2012
DPT, Physical Therapy Provo College 2006 - 2008
AS, Physical Therapist Assistant Brigham Young University 2000
BS, Physical Therapy Utah Valley University 1993
AS, Biology
Gordon Laurie Photo 33

Gordon Laurie

Location:
United States

Publications & IP owners

Us Patents

Ocular Tear Growth Factor-Like Protein

US Patent:
7320870, Jan 22, 2008
Filed:
Mar 6, 2007
Appl. No.:
11/714586
Inventors:
Gordon W. Laurie - Charlottesville VA, US
Sandhya Sanghi - Temple TX, US
Kumar Rajesh - Temple TX, US
Angela J. Lumsden - Mosman Park, AU
Assignee:
University of Virginia Patent Foundation - Charlottesville VA
International Classification:
G01N 33/53
US Classification:
435 71, 435 72, 435 691, 435 701, 530350, 436501
Abstract:
The present invention relates to a novel lacrimal gland protein (designated lacritin) and the nucleic acid sequences encoding that protein. Lacritin has activity as a growth factor on both human corneal epithelial cells and on the lacrimal acinar cells that produce it. Accordingly, one embodiment of the present invention is directed to the use of lacritin to treat Dry Eye and other disorders requiring the wetting of the eye.

Ocular Tear Growth Factor-Like Protein

US Patent:
7459440, Dec 2, 2008
Filed:
Mar 6, 2007
Appl. No.:
11/714538
Inventors:
Gordon W. Laurie - Charlottesville VA, US
Sandhya Sanghi - Temple TX, US
Kumar Rajesh - Temple TX, US
Angela J. Lumsden - Mosman Park, AU
Assignee:
University of Virginia Patent Foundation - Charlottesville VA
International Classification:
A61K 38/18
US Classification:
514 12, 514 2
Abstract:
The present invention relates to a novel lacrimal gland protein (designated lacritin) and the nucleic acid sequences encoding that protein. Lacritin has activity as a growth factor on both human corneal epithelial cells and on the lacrimal acinar cells that produce it. Accordingly, one embodiment of the present invention is directed to the use of lacritin to treat Dry Eye and other disorders requiring the wetting of the eye.

Use Of Lacritin In Promoting Ocular Cell Survival

US Patent:
7648964, Jan 19, 2010
Filed:
May 6, 2005
Appl. No.:
11/596506
Inventors:
Gordon W. Laurie - Charlottesville VA, US
Jiahu Wang - Nepean, CA
Assignee:
University of Virginia Patent Foundation - Charlottesville VA
International Classification:
A61K 38/18
C07H 21/04
C12P 21/04
C07K 14/475
US Classification:
514 12, 514 2, 435 691, 435 697, 4353201, 530300, 530399, 536 231, 536 235, 536 237
Abstract:
The present invention relates to the use of lacritin, and fragments, derivatives, and homologs thereof, and nucleic acid sequences encoding that protein. The invention relates to the use of lacritin as a growth factor human corneal epithelial cells and other select epithelial cells. The invention also relates to the use of lacritin in promoting ocular cell survival in response to an insult or injury, in protecting against ocular inflammation, and in promoting ocular wound repair.

Lacritin-Syndecan Fusion Proteins

US Patent:
7932227, Apr 26, 2011
Filed:
Sep 17, 2008
Appl. No.:
12/212517
Inventors:
Gordon W. Laurie - Charlottesville VA, US
Peisong Ma - Charlottesville VA, US
Assignee:
University of Virginia Patent Foundation - Charlottesville VA
International Classification:
A61K 38/16
A61K 38/17
C07K 14/435
US Classification:
514 12, 514 2, 530350
Abstract:
The present invention relates to methods and compositions useful for the regulation of lacritin, syndecan, and lacritin-syndecan interactions and the signaling pathway downstream of lacritin-syndecan interactions. The invention also relates to regulating lacritin-syndecan interaction to regulate ocular cell survival in response to an insult or injury, in protecting against ocular inflammation, and in promoting ocular wound repair.

Ocular Tear Growth Factor-Like Protein

US Patent:
2004008, Apr 29, 2004
Filed:
Aug 19, 2003
Appl. No.:
10/468372
Inventors:
Gordon Laurie - Charlottesville VA, US
Sandhya Sanghi - Temple TX, US
Kumar Rajesh - Temple TX, US
Angela Lumsden - Mosman Park, AU
International Classification:
C12Q001/68
C07K014/475
A61K038/18
C07H021/04
US Classification:
435/006000, 435/069100, 435/320100, 435/325000, 530/399000, 514/012000, 536/023500
Abstract:
The present invention relates to a novel lacrimal gland protein (designated lacritin) and the nucleic acid sequences encoding that protein. Lacritin has activity as a growth factor on both human corneal epithelial cells and on the lacrimal acinar cells that produce it Accordingly, one embodiment of the present invention is directed to the use of lacritin to treat Dry Eye and other disorders requiring the wetting of the eye.

Antimicrobial Activity In Variants Of Lacritin

US Patent:
2009031, Dec 17, 2009
Filed:
Sep 13, 2007
Appl. No.:
12/441178
Inventors:
Robert L. McKown - Bridgewater VA, US
Ronald W. Raab - Harrisonburg VA, US
Gordon W. Laurie - Charlottesville VA, US
Assignee:
UNIVERSITY OF VIRGINIA PATENT FOUNDATION - Charlottesville VA
International Classification:
A61K 38/00
A61K 31/7088
US Classification:
514 12, 514 44 R
Abstract:
The present invention provides recombinant proteins with antimicrobial activity and methods for treating animals including humans by administering the novel recombinant proteins. In particular, the invention provides methods for treating and/or preventing microbial diseases and infections using lacritin and homologs, fragments, modifications, and derivatives thereof.

Lacritin-Syndecan Interactions

US Patent:
2011006, Mar 17, 2011
Filed:
Nov 17, 2010
Appl. No.:
12/948199
Inventors:
Gordon W. Laurie - Charlottesville VA, US
Peisong Ma - Voorhees NJ, US
Assignee:
UNIVERSITY OF VIRGINIA PATENT FOUNDATION - Charlottesville VA
International Classification:
C12N 5/02
US Classification:
435375
Abstract:
The present invention relates to methods and compositions useful for the regulation of lacritin, syndecan, and lacritin-syndecan interactions and the signaling pathway downstream of lacritin-syndecan interactions. The invention also relates to regulating lacritin-syndecan interaction to regulate ocular cell survival in response to an insult or injury, in protecting against ocular inflammation, and in promoting ocular wound repair.

Diagnostic For Sjogren's Syndrome

US Patent:
5895812, Apr 20, 1999
Filed:
May 1, 1995
Appl. No.:
8/432055
Inventors:
Gordon W. Laurie - Charlottesville VA
Rebecca A. Ogle - Charlottesville VA
J. Douglas Glass - Charlottesville VA
Assignee:
The University of Virginia Alumni Patent Foundation - Charlottesville VA
International Classification:
C07K 1618
US Classification:
5303882
Abstract:
The present invention relates to a novel polypeptide which has secretion enhancing activity on lacrimal and parotid gland cells, monoclonal antibodies thereto, and methods of diagnosising Sjorgren's syndrome using these antibodies.

Possible Relatives

Daniel A Laurie  Donald E Laurie  Duncan A Laurie  Frances F Laurie  Gary G Laurie  J A Laurie  Jean M Laurie  Gordon E Johnson  Gordon L White  Gordon F Stark 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.